✦ LIBER ✦

Dystonia in Ashkenazi Jews: Clinical characterization of a founder mutation

✍ Scribed by Dr Susan B. Bressman; Deborah de Leon; Patricia L. Kramer; Laurie J. Ozelius; Mitchell F. Brin; Paul E. Greene; Stanley Fahn; Xandra O. Breakefield; Neil J. Risch

Publisher: John Wiley and Sons
Year: 1994
Tongue: English
Weight: 714 KB
Volume: 36
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.410360514

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sporadic alleles, including a novel muta

Sporadic alleles, including a novel mutation, characterize β-thalassemia in ashkenazi jews

✍ Ariella Oppenheim; Varda Oron; Dvora Filon; Clare C. Fearon; Eliezer A. Rachmile 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 254 KB

A deletion mutation in GJB6 cooperating

A deletion mutation in GJB6 cooperating with a GJB2 mutation in trans in non-syndromic deafness: A novel founder mutation in Ashkenazi Jews

✍ Israela Lerer; Michal Sagi; Ziva Ben-Neriah; Tieling Wang; Haya Levi; Dvorah Abe 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

A deletion of at least 140 kb starting ~35kb upstream (telomeric) to the GJB2 (CX26) gene was identified in 7 patients from 4 unrelated Jewish Ashkenazi families with non-syndromic hearing loss. These patients were heterozygous for one of the common mutations 167delT or 35delG in the GJB2 gene in tr

A low frequency of non-founder BRCA1 mut

A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast–ovarian cancer families

✍ Catherine M. Phelan; Elaine Kwan; Elaine Jack; Song Li; Cindy Morgan; Jennifer A 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

The 185delAG and 5382insC founder mutations account for the majority of mutations identified in BRCA1 in Ashkenazi Jewish breast and breast-ovarian cancer families. Few non-founder BRCA1 mutations have been identified to date in these families. We initially screened a panel of 245 Ashkenazi Jewish b

Clinical and screening implications of t

Clinical and screening implications of the I1307K adenomatous polyposis coli gene variant in Israeli Ashkenazi Jews with familial colorectal neoplasia : Evidence for a founder effect

✍ Paul Rozen; Tova Naiman; Hana Strul; Philipp Taussky; Nataly Karminsky; Ruth Sho 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

## Abstract ## BACKGROUND The authors previously found the I1307K adenomatous polyposis coli (__APC__) gene variant in 5% of Ashkenazi control participants, in 15.4% of those who had familial colorectal neoplasia, but also in 1.6% of non‐Ashkenazi control participants. In this study, they evaluate

The frequency of founder mutations in th

The frequency of founder mutations in the BRCA1, BRCA2, and APC genes in australian Ashkenazi Jews : Implications for the generality of u.s. population data

✍ Anita Y. Bahar; Peter J. Taylor; Lesley Andrews; Anne Proos; Leslie Burnett; Kat 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 1 views

A clinical, genetic, and biochemical cha

A clinical, genetic, and biochemical characterization of SPG7 mutations in a large cohort of patients with hereditary spastic paraplegia

✍ Alessia Arnoldi; Alessandra Tonelli; Francesca Crippa; Gaetano Villani; Consigli 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 471 KB 👁 1 views

Mutations in the SPG7 gene encoding a mitochondrial protein termed paraplegin, are responsible for a recessive form of hereditary spastic paraparesis. Only few studies have so far been performed in large groups of hereditary spastic paraplegia (HSP) patients to determine the frequency of SPG7 mutati